Island Pharma Names New Executive for Biodefence Push
Island Pharmaceuticals has appointed a key executive to lead operations ahead of critical US biodefence trials. The company is preparing for dose optimisation studies that could strengthen its position in the government defence sector. This strategic hire signals the firm's commitment to advancing its biodefence programme and meeting regulatory requirements for upcoming clinical trials. The appointment comes as Island Pharmaceuticals positions itself to capture opportunities in the expanding US biodefence market, where demand for innovative medical countermeasures continues to grow.
Tuesday, May 19, 2026 at 8:40 AM
0
0
0
1